XORTX Therapeutics, Inc. (XRTX)
0.9702
-0.04
(-3.94%)
USD |
NASDAQ |
Oct 20, 16:00
1.05
+0.08
(+8.23%)
After-Hours: 20:00
XORTX Therapeutics Market Cap : 1.679M for Oct. 20, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 19, 2026 | 1.748M |
| October 16, 2026 | 2.146M |
| October 15, 2026 | 2.458M |
| October 14, 2026 | 2.700M |
| October 13, 2026 | 2.907M |
| October 12, 2026 | 2.977M |
| October 09, 2026 | 2.440M |
| October 08, 2026 | 3.202M |
| October 07, 2026 | 3.020M |
| October 06, 2026 | 2.994M |
| October 05, 2026 | 2.942M |
| October 02, 2026 | 2.967M |
| October 01, 2026 | 2.994M |
| September 30, 2026 | 2.925M |
| September 29, 2026 | 2.942M |
| September 28, 2026 | 2.959M |
| September 25, 2026 | 2.925M |
| September 24, 2026 | 2.977M |
| September 23, 2026 | 2.942M |
| September 22, 2026 | 3.219M |
| September 21, 2026 | 3.375M |
| September 18, 2026 | 3.323M |
| September 17, 2026 | 2.873M |
| September 16, 2026 | 3.080M |
| September 15, 2026 | 3.254M |
| Date | Value |
|---|---|
| September 14, 2026 | 3.582M |
| September 11, 2026 | 4.032M |
| September 10, 2026 | 3.652M |
| September 09, 2026 | 3.735M |
| September 08, 2026 | 3.946M |
| September 04, 2026 | 3.998M |
| September 03, 2026 | 3.721M |
| September 02, 2026 | 4.292M |
| September 01, 2026 | 3.738M |
| August 31, 2026 | 4.015M |
| August 28, 2026 | 4.046M |
| August 27, 2026 | 4.223M |
| August 26, 2026 | 3.838M |
| August 25, 2026 | 3.911M |
| August 24, 2026 | 3.461M |
| August 21, 2026 | 3.530M |
| August 20, 2026 | 3.496M |
| August 19, 2026 | 3.461M |
| August 18, 2026 | 3.542M |
| August 17, 2026 | 3.565M |
| August 14, 2026 | 3.729M |
| August 13, 2026 | 3.79M |
| August 12, 2026 | 3.740M |
| August 11, 2026 | 3.045M |
| August 10, 2026 | 3.008M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Lexaria Bioscience Corp. | 4.371M |
| InMed Pharmaceuticals, Inc. | 7.155M |
| Target Group, Inc. (Canada) | 0.4319M |
| NervGen Pharma Corp. | 164.41M |
| Milestone Pharmaceuticals, Inc. | 88.80M |
Market Cap Related Metrics
| PEG Ratio | -0.0078 |
| Price to Book Value | 0.3050 |
| Price | 0.9702 |
| Earnings Yield | -282.9% |
| PEGY Ratio | -0.0078 |